Search research articles
Contact Us
Filters
Showing results (441-450 of 628) with videos related to
Page
of 63
Sort By:
International Journal of Clinical and Experimental Pathology
|
December 17, 2008
Evidence for the novel expression of human kallikrein-related peptidase 3, prostate-specific antigen, in the brain
Jeremy G Stone, Raj K Rolston, Masumi Ueda, et al.
Journal of Biomedicine & Biotechnology
|
October 19, 2006
Targeting gonadotropins: an alternative option for Alzheimer disease treatment
Gemma Casadesus, Emma Ramiro Puig, Kate M Webber, et al.
Journal of Alzheimer'S Disease : JAD
|
July 9, 2009
Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta
Rudy J Castellani, Hyoung-gon Lee, Sandra L Siedlak, et al.
Neurochemical Research
|
March 8, 2007
Indices of metabolic dysfunction and oxidative stress
Gemma Casadesus, Paula I Moreira, Akihiko Nunomura, et al.
Drugs in R&D
|
June 7, 2006
The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease
Gemma Casadesus, Matthew R Garrett, Kate M Webber, et al.
The Journal of Pathology
|
April 20, 2004
Prion protein is ubiquitinated after developing protease resistance in the brains of scrapie-infected mice
Shin-Chung Kang, David R Brown, Matthew Whiteman, et al.
Neuroscience Letters
|
January 30, 2002
Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans
Rudy J Castellani, George Perry, Sandra L Siedlak, et al.
Annals of the New York Academy of Sciences
|
July 19, 2005
Estrogen bows to a new master: the role of gonadotropins in Alzheimer pathogenesis
Kate M Webber, Gemma Casadesus, Michael W Marlatt, et al.
ACS Chemical Neuroscience
|
April 21, 2015
Curcumin/melatonin hybrid 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide ameliorates AD-like pathology in the APP/PS1 mouse model
Gorka Gerenu, Kai Liu, Jeremy E Chojnacki, et al.
Antioxidants & Redox Signaling
|
October 29, 2003
Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathways
Xiongwei Zhu, Arun K Raina, Hyoung-Gon Lee, et al.
Page
of 63
Search research articles
Search
Showing results (441-450 of 628) with videos related to
Sort By:
Page
of 63
International Journal of Clinical and Experimental Pathology
|
December 17, 2008
Evidence for the novel expression of human kallikrein-related peptidase 3, prostate-specific antigen, in the brain
Jeremy G Stone, Raj K Rolston, Masumi Ueda, et al.
Journal of Biomedicine & Biotechnology
|
October 19, 2006
Targeting gonadotropins: an alternative option for Alzheimer disease treatment
Gemma Casadesus, Emma Ramiro Puig, Kate M Webber, et al.
Journal of Alzheimer'S Disease : JAD
|
July 9, 2009
Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta
Rudy J Castellani, Hyoung-gon Lee, Sandra L Siedlak, et al.
Neurochemical Research
|
March 8, 2007
Indices of metabolic dysfunction and oxidative stress
Gemma Casadesus, Paula I Moreira, Akihiko Nunomura, et al.
Drugs in R&D
|
June 7, 2006
The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease
Gemma Casadesus, Matthew R Garrett, Kate M Webber, et al.
The Journal of Pathology
|
April 20, 2004
Prion protein is ubiquitinated after developing protease resistance in the brains of scrapie-infected mice
Shin-Chung Kang, David R Brown, Matthew Whiteman, et al.
Neuroscience Letters
|
January 30, 2002
Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans
Rudy J Castellani, George Perry, Sandra L Siedlak, et al.
Annals of the New York Academy of Sciences
|
July 19, 2005
Estrogen bows to a new master: the role of gonadotropins in Alzheimer pathogenesis
Kate M Webber, Gemma Casadesus, Michael W Marlatt, et al.
ACS Chemical Neuroscience
|
April 21, 2015
Curcumin/melatonin hybrid 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide ameliorates AD-like pathology in the APP/PS1 mouse model
Gorka Gerenu, Kai Liu, Jeremy E Chojnacki, et al.
Antioxidants & Redox Signaling
|
October 29, 2003
Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathways
Xiongwei Zhu, Arun K Raina, Hyoung-Gon Lee, et al.
Page
of 63